FDA Inspection 1099421 — Fresenius Kabi AB
The FDA completed an inspection of Fresenius Kabi AB on Oct 16, 2018 in Uppsala. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 16, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Uppsala (Sweden)
Additional details
Mutual Recognition Agreement (MRA)